{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:33:05Z","timestamp":1781839985423,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00066-018-1277-3","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T09:31:48Z","timestamp":1518687108000},"page":"454-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Response rates and recurrence patterns after low-dose radiotherapy with 4\u202fGy in patients with low-grade lymphomas","Ansprechraten\u00a0und Rezidivmuster nach Niedrigdosis-Bestrahlung mit 4\u00a0Gy bei Patienten mit indolenten Lymphomen"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-6694","authenticated-orcid":false,"given":"Laila","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane","family":"Hommertgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"issue":"4","key":"1277_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/1097-0142(197904)43:4<1245::AID-CNCR2820430412>3.0.CO;2-Z","volume":"43","author":"MG Chen","year":"1979","unstructured":"Chen MG et al (1979) Results of radiotherapy in control of stage I and II non-Hodgkin\u2019s lymphoma. Cancer 43(4):1245\u20131254","journal-title":"Cancer"},{"issue":"4","key":"1277_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","volume":"14","author":"MMP Manus","year":"1996","unstructured":"Manus MMP, Hoppe RT (1996) Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a\u00a0long-term follow-up study of patients treated at Stanford University. J\u00a0Clin Oncol 14(4):1282\u20131290","journal-title":"J Clin Oncol"},{"issue":"2","key":"1277_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0360-3016(98)00233-8","volume":"42","author":"MMP Manus","year":"1998","unstructured":"Manus MMP, Bowie CAR, Hoppe RT (1998) What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma? Int J Radiat Oncol Biol Phys 42(2):365\u2013371","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"NJ Senff","year":"2007","unstructured":"Senff NJ et al (2007) Reclassification of 300 primary cutaneous B\u2011Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J\u00a0Clin Oncol 25(12):1581\u20131587","journal-title":"J Clin Oncol"},{"issue":"9","key":"1277_CR5","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00761-011-2130-9","volume":"17","author":"P Koch","year":"2011","unstructured":"Koch P, Liersch R (2011) Therapie prim\u00e4rer Magenlymphome. Onkologe 17(9):814","journal-title":"Onkologe"},{"issue":"1","key":"1277_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1277_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J et\u00a0al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):11\u201331","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hon.2900120102","volume":"12","author":"G Ganem","year":"1994","unstructured":"Ganem G et al (1994) Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin\u2019s lymphomas. Hematol Oncol 12(1):1\u20138","journal-title":"Hematol Oncol"},{"issue":"1","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0360-3016(01)01626-1","volume":"51","author":"T Girinsky","year":"2001","unstructured":"Girinsky T et al (2001) A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. Int J Radiat Oncol Biol Phys 51(1):148\u2013155","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"1277_CR10","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","volume":"21","author":"RL Haas","year":"2003","unstructured":"Haas RL et al (2003) High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J\u00a0Clin Oncol 21(13):2474\u20132480","journal-title":"J Clin Oncol"},{"issue":"12","key":"1277_CR11","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.ejca.2005.04.033","volume":"41","author":"RLM Haas","year":"2005","unstructured":"Haas RLM et al (2005) Effective palliation by low dose local radiotherapy for recurrent and\/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer 41(12):1724\u20131730","journal-title":"Eur J Cancer"},{"issue":"12","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00066-017-1188-8","volume":"193","author":"K Kroeger","year":"2017","unstructured":"Kroeger K et al (2017) Low-dose total skin electron beam therapy for cutaneous lymphoma: minimal risk of acute toxicities. Strahlenther Onkol 193(12):1024\u20131030. https:\/\/doi.org\/10.1007\/s00066-017-1188-8","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1277_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","volume":"86","author":"CE Fasola","year":"2013","unstructured":"Fasola CE et al (2013) Low-dose radiation therapy (2\u202fGy x 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys 86(5):930\u2013935","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1277_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00066-016-0962-3","volume":"192","author":"L Konig","year":"2016","unstructured":"Konig L et\u00a0al (2016) Radiotherapy of indolent orbital lymphomas: two radiation concepts. Strahlenther Onkol 192(6):414\u2013421","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"1277_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hed.24717","volume":"39","author":"CC Pinnix","year":"2017","unstructured":"Pinnix CC et al (2017) Ultra-low-dose radiotherapy for definitive management of ocular adnexal B\u2011cell lymphoma. Head Neck 39(6):1095\u20131100","journal-title":"Head Neck"},{"key":"1277_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2407-11-87","volume":"11","author":"M Witzens-Harig","year":"2011","unstructured":"Witzens-Harig M et al (2011) Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a\u00a0prospective multicenter phase II trial-MIR trial. BMC Cancer 11:87","journal-title":"BMC Cancer"},{"issue":"5","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD et\u00a0al (2007) Revised response criteria for malignant lymphoma. J\u00a0Clin Oncol 25(5):579\u2013586","journal-title":"J Clin Oncol"},{"issue":"4","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00066-004-1237-y","volume":"180","author":"F Rodel","year":"2004","unstructured":"Rodel F et al (2004) The induction of TGF-beta(1) and NF-kappaB parallels a\u00a0biphasic time course of leukocyte\/endothelial cell adhesion following low-dose X\u2011irradiation. Strahlenther Onkol 180(4):194\u2013200","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2007-01-067579","volume":"110","author":"L Knoops","year":"2007","unstructured":"Knoops L et al (2007) In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma. Blood 110(4):1116\u20131122","journal-title":"Blood"},{"issue":"4","key":"1277_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","volume":"15","author":"PJ Hoskin","year":"2014","unstructured":"Hoskin PJ et al (2014) 4\u202fGy versus 24\u202fGy radiotherapy for patients with indolent lymphoma (FORT): a\u00a0randomised phase 3 non-inferiority trial. Lancet Oncol 15(4):457\u2013463","journal-title":"Lancet Oncol"},{"issue":"11","key":"1277_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00066-014-0728-8","volume":"190","author":"K Herfarth","year":"2014","unstructured":"Herfarth K, Konig L (2014) Radiation therapy (4\u202fGy vs. 24\u202fGy) in patients with indolent non-Hodgkins lymphoma: results of the FORT study. Strahlenther Onkol 190(11):1084\u20131085","journal-title":"Strahlenther Onkol"},{"issue":"21","key":"1277_CR22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V120.21.2012.2012","volume":"120","author":"K Herfarth","year":"2012","unstructured":"Herfarth K, Engelhard M, Borchmann P et al (2012) Treatment of early stage nodal follicular Lymphoma using involved-field radiotherapy and rituximab: preliminary results of the Mir trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG)). Blood 120(21):2012","journal-title":"Blood"},{"issue":"2","key":"1277_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1269\/jrr.47.183","volume":"47","author":"I Skvortsova","year":"2006","unstructured":"Skvortsova I et al (2006) Rituximab enhances radiation-triggered apoptosis in non-Hodgkin\u2019s lymphoma cells via caspase-dependent and \u2013 independent mechanisms. J\u00a0Radiat Res 47(2):183\u2013196","journal-title":"J Radiat Res"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1277-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T21:30:50Z","timestamp":1570743050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1277-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1277-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"26 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"L.\u00a0K\u00f6nig, J.\u00a0H\u00f6rner-Rieber, D.\u00a0Bernhardt, A.\u00a0Hommertgen, S.\u00a0Rieken, J.\u00a0Debus, and K.\u00a0Herfarth declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The analysis was approved by the ethics committee of our institution (S-368\/2017). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}